Temozolomide decreases invasion of glioma stem cells by down-regulating TGF-β2

Oncology Reports

Volumn 26, Issue 4, 2011, Pages 901-908

  Zhang, Dongyong ^a   Jing, Zhitao ^a   Qiu, Bo ^a   Wu, Anhua ^a   Wang, Yunjie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Glioma stem cell; Invasion; Neurospheres; Temozolomide; Transforming growth factor

Indexed keywords

MESSENGER RNA; TEMOZOLOMIDE; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CANCER STEM CELL; CELL INVASION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; GLIOMA CELL; IMMUNOMODULATION; PRIORITY JOURNAL;

CELL LINE, TUMOR; DACARBAZINE; DOWN-REGULATION; FEMALE; GLIOMA; HUMANS; MALE; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; TRANSFORMING GROWTH FACTOR BETA2; TUMOR CELLS, CULTURED;

EID: 79960801821     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1362     Document Type: Article

References (30)

1. Weller M and Fontana A: The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain. Brain Res Brain Res Rev 21: 128-151, 1995.
2. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005.
3. Singh SK, Clarke ID, Terasaki M, et al: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003.
4. Singh SK, Hawkins C, Clarke ID, et al: Identification of human brain tumour initiating cells. Nature 432: 396-401, 2004.
5. Galli R, Binda E, Orfanelli U, et al: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021, 2004.
6. Yuan X, Curtin J, Xiong Y, et al: Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23: 9392-9400, 2004.
7. Hemmati HD, Nakano I, Lazareff JA, et al: Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100: 15178-15183, 2003.
8. Platten M, Wick W, Wild-Bode C, Aulwurm S, Dichgans J and Weller M: Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via up-regulation of alpha(V)beta(3) integrin expression. Biochem Biophys Res Commun 268: 607-611, 2000.
9. Wick W, Platten M and Weller M: Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. J Neurooncol 53: 177-185, 2001.
10. Baumann F, Leukel P, Doerfelt A, et al: Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro Oncol 11: 368-380, 2009.
11. Wick W, Grimmel C, Wild-Bode C, Platten M, Arpin M and Weller M: Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2. J Neurosci 21: 3360-3368, 2001.
12. Hau P, Jachimczak P, Schlingensiepen R, et al: Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies. Oligonucleotides 17: 201-212, 2007.
13. Schneider T, Sailer M, Ansorge S, Firsching R and Reinhold D: Increased concentrations of transforming growth factor beta1 and beta2 in the plasma of patients with glioblastoma. J Neurooncol 79: 61-65, 2006.
14. Tabatabai G, Frank B, Mohle R, Weller M and Wick W: Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1 alpha-mediated induction of CXCL12. Brain 129: 2426-2435, 2006.
15. Chakravarti A, Erkkinen MG, Nestler U, et al: Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms. Clin Cancer Res 12: 4738-4746, 2006.
16. Kleihues P, Louis DN, Scheithauer BW, et al: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61: 215-226, 2002.
17. Pellegatta S, Poliani PL, Corno D, et al: Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res 66: 10247-10252, 2006.
18. Bao S, Wu Q, McLendon RE, et al: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760, 2006.
19. Wu A, Wiesner S, Xiao J, et al: Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy. J Neurooncol 83: 121-131, 2007.
20. Friese MA, Wischhusen J, Wick W, et al: RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Cancer Res 64: 7596-7603, 2004.
21. Paul DB and Kruse CA: Immunologic approaches to therapy for brain tumors. Curr Neurol Neurosci Rep 1: 238-244, 2001.
22. Qiu B, Zhang D, Wang C, et al: IL-10 and TGF-beta2 are overexpressed in tumor spheres cultured from human gliomas. Mol Biol Rep 38: 3585-3591, 2011.
23. Ji J, Black KL and Yu JS: Glioma stem cell research for the development of immunotherapy. Neurosurg Clin N Am 21: 159-166, 2010.
24. Penuelas S, Anido J, Prieto-Sanchez RM, et al: TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 15: 315-327, 2009.
25. Di Tomaso T, Mazzoleni S, Wang E, et al: Immunobiological characterization of cancer stem cells isolated from glioblastoma patients. Clin Cancer Res 16: 800-813, 2010.
26. Sanai N, Alvarez-Buylla A and Berger MS: Neural stem cells and the origin of gliomas. N Engl J Med 353: 811-822, 2005.
27. Vescovi AL, Galli R and Reynolds BA: Brain tumour stem cells. Nat Rev Cancer 6: 425-436, 2006.
28. Beier D, Rohrl S, Pillai DR, et al: Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res 68: 5706-5715, 2008.
29. Platten M, Wick W and Weller M: Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microsc Res Tech 52: 401-410, 2001.
30. Bruna A, Darken RS, Rojo F, et al: High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11: 147-160, 2007.